These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15133763)

  • 1. Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression.
    Taura K; Yamamoto Y; Nakajima A; Hata K; Uchinami H; Yonezawa K; Hatano E; Nishino N; Yamaoka Y
    J Gene Med; 2004 May; 6(5):526-36. PubMed ID: 15133763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
    Okegawa T; Nutahara K; Pong RC; Higashihara E; Hsieh JT
    J Urol; 2005 Aug; 174(2):747-52. PubMed ID: 16006969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228.
    Kitazono M; Goldsmith ME; Aikou T; Bates S; Fojo T
    Cancer Res; 2001 Sep; 61(17):6328-30. PubMed ID: 11522619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
    Okegawa T; Sayne JR; Nutahara K; Pong RC; Saboorian H; Kabbani W; Higashihara E; Hsieh JT
    J Urol; 2007 Mar; 177(3):1148-56. PubMed ID: 17296436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts.
    Yasukawa K; Sawamura D; Goto M; Nakamura H; Shimizu H
    Br J Dermatol; 2007 Oct; 157(4):662-9. PubMed ID: 17711521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells.
    Goldsmith ME; Kitazono M; Fok P; Aikou T; Bates S; Fojo T
    Clin Cancer Res; 2003 Nov; 9(14):5394-401. PubMed ID: 14614025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
    Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems.
    Goldsmith ME; Aguila A; Steadman K; Martinez A; Steinberg SM; Alley MC; Waud WR; Bates SE; Fojo T
    Mol Cancer Ther; 2007 Feb; 6(2):496-505. PubMed ID: 17308048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
    Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression.
    Nishida K; Komiyama T; Miyazawa S; Shen ZN; Furumatsu T; Doi H; Yoshida A; Yamana J; Yamamura M; Ninomiya Y; Inoue H; Asahara H
    Arthritis Rheum; 2004 Oct; 50(10):3365-76. PubMed ID: 15476220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase.
    Yamano T; Ura K; Morishita R; Nakajima H; Monden M; Kaneda Y
    Mol Ther; 2000 Jun; 1(6):574-80. PubMed ID: 10933982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.
    Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S
    Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of histone deacetylase inhibitor in adenovirus-mediated p53 gene therapy in esophageal cancer.
    Hoshino I; Matsubara H; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Komatsu A; Brooks R; Ochiai T
    Anticancer Res; 2008; 28(2A):665-71. PubMed ID: 18507005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells.
    Okada T; Uchibori R; Iwata-Okada M; Takahashi M; Nomoto T; Nonaka-Sarukawa M; Ito T; Liu Y; Mizukami H; Kume A; Kobayashi E; Ozawa K
    Mol Ther; 2006 Apr; 13(4):738-46. PubMed ID: 16387551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications in adenoviral coat fiber proteins and transcriptional regulatory sequences enhance transgene expression.
    Perlman H; Liu H; Georganas C; Woods JM; Amin MA; Koch AE; Wickham T; Kovesdi I; Mano T; Walsh K; Pope RM
    J Rheumatol; 2002 Aug; 29(8):1593-600. PubMed ID: 12180715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma.
    Yamamoto S; Yamano T; Tanaka M; Hoon DS; Takao S; Morishita R; Aikou T; Kaneda Y
    Cancer Gene Ther; 2003 Mar; 10(3):179-86. PubMed ID: 12637938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of histone deacetylase inhibitors on transcriptional regulation of the hsp70 gene in Drosophila.
    Zhao YM; Chen X; Sun H; Yuan ZG; Ren GL; Li XX; Lu J; Huang BQ
    Cell Res; 2006 Jun; 16(6):566-76. PubMed ID: 16775628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated in utero gene transfer in mice and guinea pigs: tissue distribution of recombinant adenovirus determined by quantitative TaqMan-polymerase chain reaction assay.
    Senoo M; Matsubara Y; Fujii K; Nagasaki Y; Hiratsuka M; Kure S; Uehara S; Okamura K; Yajima A; Narisawa K
    Mol Genet Metab; 2000 Apr; 69(4):269-76. PubMed ID: 10870844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer.
    Murakami J; Asaumi J; Kawai N; Tsujigiwa H; Yanagi Y; Nagatsuka H; Inoue T; Kokeguchi S; Kawasaki S; Kuroda M; Tanaka N; Matsubara N; Kishi K
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):22-8. PubMed ID: 15791453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carbon-ion radiotherapy combined with a novel histone deacetylase inhibitor, cyclic hydroxamic-acid-containing peptide 31 in human esophageal squamous cell carcinoma.
    Kano M; Yamada S; Hoshino I; Murakami K; Akutsu Y; Sakata H; Nishimori T; Usui A; Miyazawa Y; Kamada T; Tsujii H; Matsubara H
    Anticancer Res; 2009 Nov; 29(11):4433-8. PubMed ID: 20032389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.